Why is Surgery Partners stock surging today?

Surgery Partners' stock experienced a remarkable 46.3% surge in early trading due to the company's announcement of a definitive agreement to be acquired by HealthSpan Partners. This all-cash transaction valued at roughly $5.7 billion in enterprise value has left shareholders, excluding affiliates of Bain Capital, receiving $23.50 per share in cash, a 49% premium from the prior session's close of $15.75.

A crucial factor bolstering investor confidence is Bain Capital's decision to roll over its 39% equity stake into the acquiring entity, maintaining a significant stake in the company post-closing. This deal follows a previously unsuccessful attempt in 2025 for Bain Capital to take Surgery Partners private at an even higher valuation, underscoring the enduring appeal of the company's extensive network of more than 176 surgical centers and hospitals across 30 U.S. states.

An investor rights law firm has also initiated an investigation into whether the deal sufficiently compensates shareholders, a common occurrence in large take-private transactions. The overall market showed mild support, with the S&P 500 gaining 0.8% and the Nasdaq advancing 0.9%, driven by falling oil prices and expectations of a busy week of major technology earnings reports and the Federal Reserve's upcoming policy decision.

This acquisition aligns with a well-established trend in the sector, where large hospital systems are expanding into outpatient surgical settings to diversify revenue beyond traditional inpatient care. The confirmed take-private agreement at a substantial cash premium, further enhanced by Bain Capital's continued involvement and the logical synergy of the combination, fully explains today's significant move, pushing SGRY to reach $23.05 and nearing its 52-week high of $23.44.